{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:30Z","timestamp":1790035230708,"version":"4.0.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77373-8","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:35:21Z","timestamp":1788291321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vivo effect of anti-PD-1 on HIV-specific CD8+T-cells in men with HIV"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-3814","authenticated-orcid":false,"given":"C\u00e9line","family":"Gubser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Rajdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Y.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblick","family":"Brochut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Tumpach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel D.","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Judy","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajantha","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-1183","authenticated-orcid":false,"given":"Luciano","family":"Martelotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery M.","family":"Bethony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2205-9057","authenticated-orcid":false,"given":"Daniel T.","family":"Utzschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-6968","authenticated-orcid":false,"given":"Axel","family":"Kallies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-6633","authenticated-orcid":false,"given":"Jenny L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-2442","authenticated-orcid":false,"given":"Thomas A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-8241","authenticated-orcid":false,"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"77373_CR1","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks, S. G. et al. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nat. Med. 27, 2085\u20132098 (2021).","journal-title":"Nat. Med."},{"key":"77373_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi, D. et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5, 512\u2013517 (1999).","journal-title":"Nat. Med."},{"key":"77373_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1084\/jem.20170193","volume":"214","author":"NN Hosmane","year":"2017","unstructured":"Hosmane, N. N. et al. Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics. J. Exp. Med. 214, 959\u2013972 (2017).","journal-title":"J. Exp. Med."},{"key":"77373_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","volume":"20","author":"DR Collins","year":"2020","unstructured":"Collins, D. R., Gaiha, G. D. & Walker, B. D. CD8(+) T cells in HIV control, cure and prevention. Nat. Rev. Immunol. 20, 471\u2013482 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"77373_CR5","doi-asserted-by":"publisher","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","volume":"12","author":"GM Chew","year":"2016","unstructured":"Chew, G. M. et al. TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection. PLoS Pathog. 12, e1005349 (2016).","journal-title":"PLoS Pathog."},{"key":"77373_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"77373_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198\u20131202 (2006).","journal-title":"Nat. Med."},{"key":"77373_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","volume":"8","author":"DE Kaufmann","year":"2007","unstructured":"Kaufmann, D. E. et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8, 1246\u20131254 (2007).","journal-title":"Nat. Immunol."},{"key":"77373_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/QAD.0000000000002406","volume":"34","author":"BJC Macatangay","year":"2020","unstructured":"Macatangay, B. J. C. et al. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy. Aids 34, 15\u201324 (2020).","journal-title":"Aids"},{"key":"77373_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","volume":"22","author":"N Hensel","year":"2021","unstructured":"Hensel, N. et al. Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection. Nat. Immunol. 22, 229\u2013239 (2021).","journal-title":"Nat. Immunol."},{"key":"77373_CR11","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.1038\/ncomms15050","volume":"8","author":"D Wieland","year":"2017","unstructured":"Wieland, D. et al. TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation. Nat. Commun. 8, 15050 (2017).","journal-title":"Nat. Commun."},{"key":"77373_CR12","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.immuni.2021.08.007","volume":"54","author":"DR Collins","year":"2021","unstructured":"Collins, D. R. et al. Functional impairment of HIV-specific CD8(+) T cells precedes aborted spontaneous control of viremia. Immunity 54, 2372\u20132384.e2377 (2021).","journal-title":"Immunity"},{"key":"77373_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41590-024-01931-9","volume":"25","author":"E White","year":"2024","unstructured":"White, E. et al. Clonal succession after prolonged antiretroviral therapy rejuvenates CD8(+) T cell responses against HIV-1. Nat. Immunol. 25, 1555\u20131564 (2024).","journal-title":"Nat. Immunol."},{"key":"77373_CR14","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.chom.2023.08.006","volume":"31","author":"M Dube","year":"2023","unstructured":"Dube, M. et al. Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4(+) and CD8(+) T cells. Cell Host Microbe 31, 1507\u20131522.e1505 (2023).","journal-title":"Cell Host Microbe"},{"key":"77373_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.chom.2023.08.012","volume":"31","author":"H Takata","year":"2023","unstructured":"Takata, H. et al. An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8(+) T cell magnitude and short-lived differentiation status. Cell Host Microbe 31, 1494\u20131506.e1494 (2023).","journal-title":"Cell Host Microbe"},{"key":"77373_CR16","doi-asserted-by":"publisher","first-page":"103840","DOI":"10.1016\/j.ebiom.2022.103840","volume":"76","author":"C Gubser","year":"2022","unstructured":"Gubser, C., Chiu, C., Lewin, S. R. & Rasmussen, T. A. Immune checkpoint blockade in HIV. Ebiomedicine 76, 103840 (2022).","journal-title":"Ebiomedicine"},{"key":"77373_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/imr.13388","volume":"328","author":"HAD King","year":"2024","unstructured":"King, H. A. D. & Lewin, S. R. Immune checkpoint inhibitors in infectious disease. Immunol. Rev. 328, 350\u2013371 (2024).","journal-title":"Immunol. Rev."},{"key":"77373_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8(+) T cell subsets reveal underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841.e828 (2020).","journal-title":"Immunity"},{"key":"77373_CR19","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits the durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"77373_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41590-022-01338-4","volume":"23","author":"JR Giles","year":"2022","unstructured":"Giles, J. R. et al. Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat. Immunol. 23, 1600\u20131613 (2022).","journal-title":"Nat. Immunol."},{"key":"77373_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265\u2013276 (2015).","journal-title":"Trends Immunol."},{"key":"77373_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"77373_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.3543","volume":"17","author":"YA Leong","year":"2016","unstructured":"Leong, Y. A. et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat. Immunol. 17, 1187 (2016).","journal-title":"Nat. Immunol."},{"key":"77373_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195 (2019).","journal-title":"Immunity"},{"key":"77373_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"77373_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326 (2019).","journal-title":"Nat. Immunol."},{"key":"77373_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2019","unstructured":"Kallies, A., Zehn, D. & Utzschneider, D. T. Precursor exhausted T cells: key to successful immunotherapy? Nat. Rev. Immunol. 20, 128\u2013136 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"77373_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60 (2017).","journal-title":"Nature"},{"key":"77373_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41591-019-0357-y","volume":"25","author":"AC Huang","year":"2019","unstructured":"Huang, A. C. et al. A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma. Nat. Med. 25, 454\u2013461 (2019).","journal-title":"Nat. Med."},{"key":"77373_CR30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"77373_CR31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/QAD.0000000000002919","volume":"35","author":"JSY Lau","year":"2021","unstructured":"Lau, J. S. Y. et al. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy. Aids 35, 1631\u20131636 (2021).","journal-title":"Aids"},{"key":"77373_CR32","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/annonc\/mdy259","volume":"29","author":"EP Scully","year":"2018","unstructured":"Scully, E. P. et al. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection. Ann. Oncol. 29, 2141\u20132142 (2018).","journal-title":"Ann. Oncol."},{"key":"77373_CR33","doi-asserted-by":"publisher","first-page":"e0211112","DOI":"10.1371\/journal.pone.0211112","volume":"14","author":"JK Bui","year":"2019","unstructured":"Bui, J. K. et al. Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART. PLOS ONE 14, e0211112 (2019).","journal-title":"PLOS ONE"},{"key":"77373_CR34","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/infdis\/jix191","volume":"215","author":"CL Gay","year":"2017","unstructured":"Gay, C. L. et al. Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy. J. Infect. Dis. 215, 1725\u20131733 (2017).","journal-title":"J. Infect. Dis."},{"key":"77373_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad694","volume":"11","author":"CL Gay","year":"2024","unstructured":"Gay, C. L. et al. Safety and immune responses following anti-PD-1 monoclonal antibody infusions in healthy persons with human immunodeficiency virus on antiretroviral therapy. Open Forum Infect. Dis. 11, ofad694 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"77373_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41591-025-04139-y","volume":"32","author":"A Talla","year":"2026","unstructured":"Talla, A. et al. Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy. Nat. Med. 32, 505\u2013517 (2026).","journal-title":"Nat. Med."},{"key":"77373_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin, P., Toor, S. M., Sasidharan Nair, V. & Elkord, E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp. Mol. Med. 50, 1\u201311 (2018).","journal-title":"Exp. Mol. Med."},{"key":"77373_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","volume":"36","author":"R Orenbuch","year":"2020","unstructured":"Orenbuch, R. et al. arcasHLA: high-resolution HLA typing from RNAseq. Bioinformatics 36, 33\u201340 (2020).","journal-title":"Bioinformatics"},{"key":"77373_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4049\/jimmunol.1100316","volume":"187","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Multilayered defense in HLA-B51-associated HIV viral control. J. Immunol. 187, 684\u2013691 (2011).","journal-title":"J. Immunol."},{"key":"77373_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"77373_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405\u2013411 (2020).","journal-title":"Science"},{"key":"77373_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897569","volume":"13","author":"W Hu","year":"2022","unstructured":"Hu, W. et al. CCL5-secreting virtual memory CD8+ T cells inversely associate with viral reservoir size in HIV-1-infected individuals on antiretroviral therapy. Front. Immunol. 13, 897569 (2022).","journal-title":"Front. Immunol."},{"key":"77373_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41421-021-00367-x","volume":"8","author":"XM Wang","year":"2022","unstructured":"Wang, X. M. et al. Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection. Cell Discov. 8, 29 (2022).","journal-title":"Cell Discov."},{"key":"77373_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","volume":"609","author":"C Tsui","year":"2022","unstructured":"Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature 609, 354\u2013360 (2022).","journal-title":"Nature"},{"key":"77373_CR45","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1080\/22221751.2020.1826361","volume":"9","author":"SB Wang","year":"2020","unstructured":"Wang, S. B. et al. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg. Microbes Infect. 9, 2333\u20132347 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"77373_CR46","doi-asserted-by":"publisher","first-page":"2344905","DOI":"10.1080\/2162402X.2024.2344905","volume":"13","author":"YW Chen","year":"2024","unstructured":"Chen, Y. W. et al. The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity. Oncoimmunology 13, 2344905 (2024).","journal-title":"Oncoimmunology"},{"key":"77373_CR47","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach, C. et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity 45, 1270\u20131284 (2016).","journal-title":"Immunity"},{"key":"77373_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21619-0","volume":"12","author":"T Yamauchi","year":"2021","unstructured":"Yamauchi, T. et al. T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nat. Commun. 12, 1402 (2021).","journal-title":"Nat. Commun."},{"key":"77373_CR49","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/s41590-022-01337-5","volume":"23","author":"B Daniel","year":"2022","unstructured":"Daniel, B. et al. Divergent clonal differentiation trajectories of T cell exhaustion. Nat. Immunol. 23, 1614 (2022).","journal-title":"Nat. Immunol."},{"key":"77373_CR50","unstructured":"Uldrick, T. S. et al. Pembrolizumab induces HIV latency reversal in HIV+ individuals on ART with cancer. in CROI (Seattle, 2019)."},{"key":"77373_CR51","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/QAD.0000000000001849","volume":"32","author":"VA Evans","year":"2018","unstructured":"Evans, V. A. et al. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency. Aids 32, 1491\u20131497 (2018).","journal-title":"Aids"},{"key":"77373_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08798-7","volume":"10","author":"R Fromentin","year":"2019","unstructured":"Fromentin, R. et al. PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals. Nat. Commun. 10, 814 (2019).","journal-title":"Nat. Commun."},{"key":"77373_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ebiom.2019.02.006","volume":"41","author":"C Van Hecke","year":"2019","unstructured":"Van Hecke, C. et al. Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors. Ebiomedicine 41, 443\u2013454 (2019).","journal-title":"Ebiomedicine"},{"key":"77373_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/QAD.0000000000003428","volume":"37","author":"DA Siegel","year":"2023","unstructured":"Siegel, D. A. et al. Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predicts viral reservoir size. Aids 37, 477\u2013488 (2023).","journal-title":"Aids"},{"key":"77373_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41586-025-09932-w","volume":"650","author":"Z Kiani","year":"2026","unstructured":"Kiani, Z. et al. CD8(+) T cell stemness precedes post-intervention control of HIV viremia. Nature 650, 196\u2013204 (2026).","journal-title":"Nature"},{"key":"77373_CR56","doi-asserted-by":"publisher","unstructured":"Peluso, M. J. et al. Rutishauser Correlates of HIV-1 control after combination immunotherapy. Nature 650, 187\u2013195 https:\/\/doi.org\/10.1038\/s41586-025-09929-5 (2026).","DOI":"10.1038\/s41586-025-09929-5"},{"key":"77373_CR57","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.immuni.2024.08.005","volume":"57","author":"C Saggau","year":"2024","unstructured":"Saggau, C. et al. Autoantigen-specific CD4(+) T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases. Immunity 57, 2416\u20132432.e2418 (2024).","journal-title":"Immunity"},{"key":"77373_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04893-3","volume":"9","author":"CS Baron","year":"2018","unstructured":"Baron, C. S. et al. Single-cell transcriptomics reveal the dynamics of hematopoietic stem cell production in the aorta. Nat. Commun. 9, 2517 (2018).","journal-title":"Nat. Commun."},{"key":"77373_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/2326-6066.CIR-20-0398","volume":"9","author":"DS Bortone","year":"2021","unstructured":"Bortone, D. S., Woodcock, M. G., Parker, J. S. & Vincent, B. G. Improved T-cell receptor diversity estimates associate with survival and response to anti-PD-1 therapy. Cancer Immunol. Res. 9, 103\u2013112 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"77373_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat. Cancer 3, 108\u2013121 (2022).","journal-title":"Nat. Cancer"},{"key":"77373_CR61","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell 188, 3081\u20133096.e3019 (2025).","journal-title":"Cell"},{"key":"77373_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14776-8","volume":"25","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Anti-PD-1 therapy achieves a favorable outcome in gastric cancer combined with chronic hepatitis B. BMC Cancer 25, 1354 (2025).","journal-title":"BMC Cancer"},{"key":"77373_CR63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira, G. & Wu, C. J. Dynamics and specificities of T cells in cancer immunotherapy. Nat. Rev. Cancer 23, 295\u2013316 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"77373_CR64","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1128\/JVI.73.7.6099-6103.1999","volume":"73","author":"SR Lewin","year":"1999","unstructured":"Lewin, S. R. et al. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J. Virol. 73, 6099\u20136103 (1999).","journal-title":"J. Virol."},{"key":"77373_CR65","doi-asserted-by":"publisher","first-page":"e142640","DOI":"10.1172\/jci.insight.142640","volume":"6","author":"EM Stevenson","year":"2021","unstructured":"Stevenson, E. M. et al. HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy. JCI Insight 6, e142640 (2021).","journal-title":"JCI Insight"},{"key":"77373_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl3836","volume":"14","author":"TS Uldrick","year":"2022","unstructured":"Uldrick, T. S. et al. Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy. Sci. Transl. Med. 14, eabl3836 (2022).","journal-title":"Sci. Transl. Med."},{"key":"77373_CR67","doi-asserted-by":"publisher","first-page":"e1973","DOI":"10.1093\/cid\/ciaa1530","volume":"73","author":"TA Rasmussen","year":"2021","unstructured":"Rasmussen, T. A. et al. Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in people living with HIV with cancer on antiretroviral therapy: The AIDS Malignancy Consortium-095 study. Clin. Infect. Dis. 73, e1973\u2013e1981 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"77373_CR68","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1172\/JCI132374","volume":"130","author":"Y Ren","year":"2020","unstructured":"Ren, Y. et al. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo. J. Clin. Invest. 130, 2542\u20132559 (2020).","journal-title":"J. Clin. Invest."},{"key":"77373_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner, K. M. et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566, 120\u2013125 (2019).","journal-title":"Nature"},{"key":"77373_CR70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12985-024-02300-6","volume":"21","author":"N Buchholtz","year":"2024","unstructured":"Buchholtz, N. et al. Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C. Virol. J. 21, 36 (2024).","journal-title":"Virol. J."},{"key":"77373_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/infdis\/jiaa718","volume":"224","author":"SD Falcinelli","year":"2021","unstructured":"Falcinelli, S. D. et al. Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of individuals receiving antiretroviral therapy. J. Infect. Dis. 224, 92\u2013100 (2021).","journal-title":"J. Infect. Dis."},{"key":"77373_CR72","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cell.2021.12.011","volume":"185","author":"KB Einkauf","year":"2022","unstructured":"Einkauf, K. B. et al. Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses. Cell 185, 266\u2013282.e215 (2022).","journal-title":"Cell"},{"key":"77373_CR73","doi-asserted-by":"publisher","first-page":"e01163","DOI":"10.1128\/AAC.01163-19","volume":"63","author":"E Bekerman","year":"2019","unstructured":"Bekerman, E. et al. PD-1 blockade and TLR7 activation lack therapeutic benefit in chronic simian immunodeficiency virus-infected macaques on antiretroviral therapy. Antimicrob. Agents Chemother. 63, e01163\u2013e01219 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77373_CR74","doi-asserted-by":"publisher","first-page":"e122940","DOI":"10.1172\/jci.insight.122940","volume":"3","author":"GH Mylvaganam","year":"2019","unstructured":"Mylvaganam, G. H. et al. Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV. JCI Insight 3, e122940 (2019).","journal-title":"JCI Insight"},{"key":"77373_CR75","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1172\/JCI60612","volume":"122","author":"RD Shetty","year":"2012","unstructured":"Shetty, R. D. et al. PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. J. Clin. Invest. 122, 1712\u20131716 (2012).","journal-title":"J. Clin. Invest."},{"key":"77373_CR76","doi-asserted-by":"publisher","first-page":"e1010245","DOI":"10.1371\/journal.ppat.1010245","volume":"18","author":"AA Okoye","year":"2022","unstructured":"Okoye, A. A. et al. The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription. PLoS Pathog. 18, e1010245 (2022).","journal-title":"PLoS Pathog."},{"key":"77373_CR77","first-page":"692","volume":"24","author":"M Ramgopal","year":"2023","unstructured":"Ramgopal, M. et al. Safety, pharmacokinetics, and exploratory efficacy of the PD-1 inhibitor budigalimab in antiretroviral treatment-suppressed people living with HIV-1: Preliminary analysis of 2 phase 1b studies including an analytical treatment interruption. Hiv. Med 24, 692\u2013693 (2023).","journal-title":"Hiv. Med"},{"key":"77373_CR78","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1038\/s41467-023-40745-5","volume":"14","author":"S Hiltbrunner","year":"2023","unstructured":"Hiltbrunner, S. et al. Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with an immunosuppressive T cell phenotype. Nat. Commun. 14, 5154 (2023).","journal-title":"Nat. Commun."},{"key":"77373_CR79","doi-asserted-by":"publisher","first-page":"108165","DOI":"10.1016\/j.isci.2023.108165","volume":"26","author":"C Gubser","year":"2023","unstructured":"Gubser, C. et al. GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy. iScience 26, 108165 (2023).","journal-title":"iScience"},{"key":"77373_CR80","doi-asserted-by":"publisher","first-page":"103231","DOI":"10.1016\/j.xpro.2024.103231","volume":"5","author":"C Gubser","year":"2024","unstructured":"Gubser, C., Pascoe, R. D., Trautmann, L., Rasmussen, T. A. & Lewin, S. R. Protocol for measuring killing capacity and intracellular cytokine production of human HIV antigen-specific CD8 T cells using flow cytometry. Star Protoc. 5, 103231 (2024).","journal-title":"Star Protoc."},{"key":"77373_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106004","volume":"122","author":"RD Pascoe","year":"2025","unstructured":"Pascoe, R. D. et al. Pomalidomide enhances CD8(+) T and NK cell-mediated killing of HIV-infected cells. Ebiomedicine 122, 106004 (2025).","journal-title":"Ebiomedicine"},{"key":"77373_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.forsciint.2004.12.011","volume":"154","author":"LA Dixon","year":"2005","unstructured":"Dixon, L. A. et al. Validation of a 21-locus autosomal SNP multiplex for forensic identification purposes. Forensic Sci. Int 154, 62\u201377 (2005).","journal-title":"Forensic Sci. Int"},{"key":"77373_CR83","doi-asserted-by":"publisher","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","volume":"10","author":"JH Elliott","year":"2014","unstructured":"Elliott, J. H. et al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog. 10, e1004473 (2014).","journal-title":"PLoS Pathog."},{"key":"77373_CR84","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/S2352-3018(18)30040-7","volume":"5","author":"TA Rasmussen","year":"2018","unstructured":"Rasmussen, T. A. et al. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. Lancet HIV 5, e221\u2013e230 (2018).","journal-title":"Lancet HIV"},{"key":"77373_CR85","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"77373_CR86","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"77373_CR87","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"77373_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1865-2","volume":"20","author":"Y Huang","year":"2019","unstructured":"Huang, Y., McCarthy, D. J. & Stegle, O. Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 20, 273 (2019).","journal-title":"Genome Biol."},{"key":"77373_CR89","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"77373_CR90","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/bioinformatics\/btab209","volume":"37","author":"JF Ouyang","year":"2021","unstructured":"Ouyang, J. F., Kamaraj, U. S., Cao, E. Y. & Rackham, O. J. L. ShinyCell: simple and sharable visualization of single-cell gene expression data. Bioinformatics 37, 3374\u20133376 (2021).","journal-title":"Bioinformatics"},{"key":"77373_CR91","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"77373_CR92","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","volume":"38","author":"B Phipson","year":"2022","unstructured":"Phipson, B. et al. propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720\u20134726 (2022).","journal-title":"Bioinformatics"},{"key":"77373_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41587-023-01734-7","volume":"42","author":"C Suo","year":"2023","unstructured":"Suo, C. et al. Dandelion uses the single-cell adaptive immune receptor repertoire to explore lymphocyte developmental origins. Nat. Biotechnol. 42, 40\u201351 (2023).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77373-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:02:35Z","timestamp":1790031755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77373-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77373"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77373-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SRL has received funding from the National Health and Medical Research Council of Australia (NHMRC), the National Institutes of Health (NIH), amfAR, The Australian Center for HIV and Hepatitis Research, Melbourne HIV Cure Consortium, Gilead Sciences, Merck, ViiV, AbbVie and Gilead outside the submitted work. TAR has received funding from the Danish Research Council, Region Midt Denmark, Novo Nordisk Foundation, The Australian Center for HIV and Hepatitis Research, Melbourne HIV Cure Consortium and Gilead outside the submitted work. CG has received funding from Novartis and the Doherty Grant Program outside the submitted work. RDP has received funding from the Melbourne HIV Cure Consortium outside this work. JS and JA have received funding from the J and M Wright Foundation outside the submitted work. CMD received funding from the NIH (K23CA177321) related to this work. CMD receives payments from Gilead Sciences for serving on a grant review committee and is a principal investigator on clinical trials for which Gilead donates drug product outside of this work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10024"}}